Notice of Annual General Meeting
The Company announces that its notice of Annual General Meeting has been posted to shareholders. The AGM will be held at 2.30pm on Friday 24 July 2009 at the offices of Buchanan Communications, 45 Moorfields, London EC2Y 9AE. more...
Lipoxen is a leading UK based biopharmaceutical company providing specialist delivery solutions to improve the efficacy and performance of drugs and vaccines in a variety of important medical areas.
Working with some of the largest pharmaceutical organisations in the world, Lipoxen provides leading edge expertise in the development of a whole new generation of drugs and vaccines.
An advanced enabling technology that uses novel polymer and liposome based-constructs:
A portfolio with multi-billion dollar potential
Lipoxen's supergenerics product pipeline is based on its drug and vaccine delivery proprietary technologies. Our unique delivery technologies have the capacity to create new high-value, differentiated proprietary products. READ MORE...
The information in this website has been disclosed for the purposes of Rule 26 of the AIM Rules for companies (February 2007) and was last updated on 03 July 2009.